Skip to main content
. 2023 Nov 29;8(3):224–235. doi: 10.3138/jammi-2023-0004

Table 2:

Infection characteristics among included studies and patients

No. (%) of studies; n = 24 No. (%) of patients; n = 5705 Study citations
Patients with multiple abscesses 13 (54) 780 (13.7) (3,5,6,18–22,30–35)
Abscess etiology 16 (66.7) 3,190/5,705 (55.9) (1,3,4,6,19–22,25–30,34–36)
Hematogenous 6 (37.5) 48/3190 (1.5) (1,27–29,34,35)
Biliary tract 15 (62.5) 1,328/3190 (41.6) (1,3,4,6,19–22,27–30,34,35)
Portal vein 5 (31.3) 63/3190 (2.0) (27–29,35,36)
Contiguous/Trauma 3 (18.8) 117/3190 (3.7) (6,21,35)
Cryptogenic 13 (54.2) 1,427/3190 (44.7) (1,3,4,6,19–22,27–29,35,36)
Diabetes 1 (6.3) 8/3190 (0.25) (1)
Post surgical 4 (25) 49/3190 (1.5) (21,25,34,36)
Unknown 4 (25) 150/3190 (4.7) (20,21,27,29)
Concurrent bacteremia 13 (54.2) 1393/3649 (38.2) (3–6,18,21,22,27,30,31,34–36)
Treated with antibiotics alone 20 (83.3) 827/5705 (14.5) (1,3–6,18–29,34,35)
Surgical intervention 22 (91.7) 4366/5705 (76.5) (1,3–6,18–30,33–36)
Image guided aspiration 13 (54.2) 1484/4366 (34.0) (6,19–22,25–30)
Percutaneous image guided drainage 15 (62.5) 2055/4366 (47.1) (1,4,5,20–27,29,33–35)
Surgical drainage 17 (70.8) 187/4366 (4.3) (1,3–5,18–22,25–29,33,35,36)
Unspecified drainage 4 (16.7) 569/4366 (13.0) (3,18,30,36)
Endoscopic retrograde cholangiopancreatography 2 (8.3) 71/4366 (1.6) (1,34)